Compounds > gemcitabine
Page last updated: 2024-08-24

gemcitabine and Cold Fingers, Hereditary

gemcitabine has been researched along with Cold Fingers, Hereditary in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's3 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Banno, S; Imai, H; Kawai, H; Miura, N; Nobata, H; Suzuki, K; Wakamatsu, R; Yamada, Y1
Chiba, T; Ishikawa, S; Kanai, M; Kawaguchi, Y; Masui, T; Matsumoto, S; Mimori, T; Mori, Y; Nishimura, T; Yanagihara, K; Zaima, C1
Gupta, MK; Madabhavi, I; Rastogi, M; Revannasiddaiah, S1

Other Studies

3 other study(ies) available for gemcitabine and Cold Fingers, Hereditary

ArticleYear
Gemcitabine-induced hemolytic uremic syndrome mimicking scleroderma renal crisis presenting with Raynaud's phenomenon, positive antinuclear antibodies and hypertensive emergency.
    Internal medicine (Tokyo, Japan), 2014, Volume: 53, Issue:5

    Topics: Antibodies, Antinuclear; Blood Pressure; Deoxycytidine; Diagnosis, Differential; Emergencies; Female; Gallbladder Neoplasms; Gemcitabine; Hemolytic-Uremic Syndrome; Humans; Hypertension, Malignant; Immunosuppressive Agents; Kidney Glomerulus; Middle Aged; Raynaud Disease; Ribonucleotide Reductases; Scleroderma, Systemic

2014
A case of progressive digital ischemia after early withdrawal of gemcitabine and S-1 in a patient with systemic sclerosis.
    Japanese journal of clinical oncology, 2011, Volume: 41, Issue:6

    Topics: Aged; Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Deoxycytidine; Disease Progression; Drug Administration Schedule; Drug Combinations; Fatal Outcome; Fingers; Gangrene; Gemcitabine; Humans; Ischemia; Male; Necrosis; Oxonic Acid; Pancreatic Neoplasms; Peritoneal Neoplasms; Raynaud Disease; Scleroderma, Systemic; Tegafur; Toes

2011
Paraneoplastic Raynaud's phenomenon manifesting before the diagnosis of lung cancer.
    BMJ case reports, 2012, Jul-03, Volume: 2012

    Topics: Adenocarcinoma; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Deoxycytidine; Gemcitabine; Humans; Lung Neoplasms; Male; Middle Aged; Paraneoplastic Syndromes; Raynaud Disease

2012